Willems L, Burny A, Collete D, Dangoisse O, Dequiedt F, Gatot JS, Kerkhofs P, Lefebvre L, Merezak C, Peremans T, Portetelle D, Twizere JC, Kettmann R: Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses 2000, 16: 1787-1795.
Kettmann R, Meunier-Rotival M, Cortadas J, Cuny G, Ghysdael J, Mammerickx M, Burny A, Bernardi G: Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A 1979, 76:4822-4826.
Longo DL, Gelmann EP, Cossman J, Young RA, Gallo RC, O'Brien SJ, Matis LA: Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature 1984, 310:505-506.
Seiki M, Hattori S, Yoshida M: Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci U S A 1982, 79:6899-6902.
Kettmann R, Cleuter Y, Mammerickx M, Meunier-Rotival M, Bernardi G, Burny A, Chantrenne H: Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A 1980, 77: 2577-2581.
Seiki M, Eddy R, Shows TB, Yoshida M: Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature 1984, 309:640-642.
Burny A, Cleuter Y, Kettmann R, Mammerickx M, Marbaix G, Portetelle D, Van den Broeke A., Willems L, Thomas R: Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol 1988, 17:197-218.
Mammerickx M, Palm R, Portetelle D, Burny A: Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease. Leukemia 1988, 2:103-107.
Miller JM, Miller LD, Olson C, Gillette KG: Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst 1969, 43:1297-1305.
Meiron R, Brenner J, Gluckman A, Avraham R, Trainin Z: Humoral and cellular responses in calves experimentally infected with bovine leukemia virus (BLV). Vet Immunol Immunopathol 1985, 9:105-114.
Dimmock CK, Ward WH, Trueman KF: Lymphocyte subpopulations in sheep during the early stage of experimental infection with bovine leukaemia virus. Immunol Cell Biol 1989, 67 ( Pt 2): 141-145.
Klintevall K, Fuxler L, Fossum C: Bovine leukemia virus: early reflections in blood after an experimental infection of calves. Comp Immunol Microbiol Infect Dis 1997, 20:119-130.
Depelchin A, Letesson JJ, Lostrie-Trussart N, Mammerickx M, Portetelle D, Burny A: Bovine leukemia virus (BLV)-infected B-cells express a marker similar to the CD5 T cell marker. Immunol Lett 1989, 20:69-76.
Schwartz I, Bensaid A, Polack B, Perrin B, Berthelemy M, Levy D: In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle. J Virol 1994, 68:4589-4596.
Cantor GH, Pritchard SM, Dequiedt F, Willems L, Kettmann R, Davis WC: CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis. J Virol 2001, 75:1689-1696.
Ferrer JF, Marshak RR, Abt DA, Kenyon SJ: Persistent lymphocytosis in cattle: its cause, nature and relation to lymphosarcoma. Ann Rech Vet 1978, 9:851-857.
Willems L, Kettmann R, Dequiedt F, Portetelle D, Voneche V, Cornil I, Kerkhofs P, Burny A, Mammerickx M: In vivo infection of sheep by bovine leukemia virus mutants. J Virol 1993, 67: 4078-4085.
Willems L, Kerkhofs P, Dequiedt F, Portetelle D, Mammerickx M, Burny A, Kettmann R: Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A 1994, 91:11532-11536.
Kerkhofs P, Heremans H, Burny A, Kettmann R, Willems L: In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol 1998, 72:2554-2559.
Merezak C, Pierreux C, Adam E, Lemaigre F, Rousseau GG, Calomme C, Van Lint C, Christophe D, Kerkhofs P, Burny A, Kettmann R, Willems L: Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol 2001, 75:6977-6988.
Gatot JS, Callebaut I, Mornon JP, Portetelle D, Burny A, Kerkhofs P, Kettmann R, Willems L: Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo. J Biol Chem 1998, 273:12870-12880.
Murakami K, Okada K, Ikawa Y, Aida Y: Bovine leukemia virus induces CD5- B cell lymphoma in sheep despite temporarily increasing CD5+ B cells in asymptomatic stage. Virology 1994, 202:458-465.
Chevallier N, Berthelemy M, Le Rhun D, Laine V, Levy D, Schwartz-Cornil I: Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep. J Virol 1998, 72:4413-4420.
Debacq C, Asquith B, Kerkhofs P, Portetelle D, Burny A, Kettmann R, Willems L: Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virusinfected sheep. Proc Natl Acad Sci U S A 2002, 99:10048-10053.
Lew AE, Bock RE, Miles J, Cuttell LB, Steer P, Nadin-Davis SA: Sensitive and specific detection of bovine immunodeficiency virus and bovine syncytial virus by 5′ Taq nuclease assays with fluorescent 3′ minor groove binder-DNA probes. J Virol Methods 2004, 116:1-9.
Young AJ: The physiology of lymphocyte migration through the single lymph node in vivo 3. Semin Immunol 1999, 11: 73-83.
Hayakawa K, Hardy RR: Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? Annu Rev Immunol 1988, 6: 197-218.
Dauphinee M, Tovar Z, Talal N: B cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum 1988, 31: 642-647.
Youinou P, Mackenzie L, Katsikis P, Merdrignac G, Isenberg DA, Tuaillon N, Lamour A, Le Goff P, Jouquan J, Drogou A, .: The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum 1990, 33:339-348.
Kouri YH, Basch RS, Karpatkin S: B-cell subsets and platelet counts in HIV-1 seropositive subjects. Lancet 1992, 339:1445-1446.
Ikematsu W, Ikematsu H, Okamura S, Otsuka T, Harada M, Niho Y: Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia. Blood 1994, 83:2602-2610.
Berland R, Wortis HH: Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002, 20: 253-300.
Baumgarth N: A two-phase model of B-cell activation. Immunol Rev 2000, 176:171-180.
Sharma R, Woldehiwet Z: Lymphocyte subpopulations in peripheral blood of lambs experimentally infected with Pasteurella haemolytica. Vet Microbiol 1991, 27:159-168.
Onah DN, Hopkins J, Luckins AG: Increase in CD5+ B cells and depression of immune responses in sheep infected with Trypanosoma evansi. Vet Immunol Immunopathol 1998, 63:209-222.
Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G: HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 2001, 98:823-829.
Kim SJ, Ding W, Albrecht B, Green PL, Lairmore MD: A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J Biol Chem 2003, 278:15550-15557.
Ding W, Kim SJ, Nair AM, Michael B, Boris-Lawrie K, Tripp A, Feuer G, Lairmore MD: Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol 2003, 77:11027-11039.
Lefebvre L, Vanderplasschen A, Ciminale V, Heremans H, Dangoisse O, Jauniaux JC, Toussaint JF, Zelnik V, Burny A, Kettmann R, Willems L: Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol 2002, 76:1400-1414.
Silic-Benussi M, Cavallari I, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, Ciminale V: Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type. Proc Natl Acad Sci U S A 2004, 101:6629-6634.
Portetelle D, Mammerickx M, Burny A: Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods 1989, 23:211-222.
Dequiedt F, Hanon E, Kerkhofs P, Pastoret PP, Portetelle D, Burny A, Kettmann R, Willems L: Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol 1997, 71:630-639.
Rice NR, Simek SL, Dubois GC, Showalter SD, Gilden RV, Stephens RM: Expression of the bovine leukemia virus X region in virus-infected cells. J Virol 1987, 61:1577-1585.